This article has Open Peer Review reports available.
Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
© The Author(s). 2018
Received: 6 February 2017
Accepted: 22 December 2017
Published: 3 January 2018
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|6 Feb 2017||Submitted||Original manuscript|
|22 Feb 2017||Reviewed||Reviewer Report - Elise Kohn|
|15 Apr 2017||Reviewed||Reviewer Report - Christina Annunziata|
|21 Apr 2017||Author responded||Author comments - Robert Hollis|
|Resubmission - Version 2|
|21 Apr 2017||Submitted||Manuscript version 2|
|23 Oct 2017||Author responded||Author comments - Robert Hollis|
|Resubmission - Version 3|
|23 Oct 2017||Submitted||Manuscript version 3|
|22 Dec 2017||Editorially accepted|
|3 Jan 2018||Article published||10.1186/s12885-017-3981-2|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.